Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00166608 · ClinicalTrials.gov registry record
Cytokines Polymorphisms and Acetaminophen Toxicity
A clinical trial, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- 111
- Enrollment target
NCT00166608 is a clinical trial that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 111 participants.
The verdict
NCT00166608 has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
Study Summary
Genotyping assays for polymorphisms in the interleukin 10(IL10)gene and the inducible nitric oxide synthase (iNOS) gene will be performed. Genotypes will be compared to the severity of toxicity following overdose.
Interventions
- PROCEDURE Blood sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2002-12 |
| Est. Completion | 2007-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00166608
The ClinicalTrials.gov registry entry for NCT00166608 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arkansas Children's Hospital Research Institute, which has 97 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood sampling is the first listed.
NCT00166608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00166608 about?
NCT00166608 is a clinical study titled "Cytokines Polymorphisms and Acetaminophen Toxicity". Genotyping assays for polymorphisms in the interleukin 10(IL10)gene and the inducible nitric oxide synthase (iNOS) gene will be performed. Genotypes will be compared to the severity of toxicity following overdose.
What is the current status of trial NCT00166608?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2002-12. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00166608?
The interventions under investigation include: Blood sampling (PROCEDURE).
Who is sponsoring clinical trial NCT00166608?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.